Molecular Diagnostics Market Outlook 2028

  • The global molecular diagnostics market was valued at US$ 14.99 Mn in 2020
  • It is estimated to expand at a CAGR of 11.1% from 2021 to 2028
  • The global molecular diagnostics market is expected to reach the value of US$ 37.19 Bn by the end of 2028

Analysts’ Viewpoint on Molecular Diagnostics Market Scenario

Even though elective procedures have been postponed indefinitely during the ongoing COVID-19 outbreak, healthcare facilities are ensuring continuity in services for key sectors such as blood screening and detection of infectious diseases, among others. However, in many cases, it has been found that late diagnosis of any disease results in rise in the cost of treatment. Hence, companies in the molecular diagnostics market should increase R&D to enable early detection of diseases and invest in marketing of tests to increase awareness about its advantages for early disease diagnosis. Alternatively, the strong growth of molecular diagnostics in Germany can be attributed to the government’s focus on healthcare investments, enhancing the biotechnology sector, and increasing the number of biotechnology companies in the country.

North America and Asia Pacific Witnessing Change in Molecular Diagnostics

North America dominated the global molecular diagnostics market in 2020, followed by Europe. The region's dominance can be attributed to the increase in diagnostic facilities and emergence of new players in the region. North America is the leading market for molecular diagnostics due to rise in investments by governments in support of molecular diagnostic tests. Surge in incidence of cancer and unhealthy lifestyle leading to severe infectious diseases are fueling growth of the molecular diagnostics market in the region. Other factors such as large geriatric population and rise in demand for personalized medicines are expected to augment the market in North America.

Emerging markets in Asia Pacific hold immense growth potential due to initiatives taken by governments to promote healthcare and robust economic growth. Moreover, improving purchasing power, consumer awareness about health issues, and better disease management are expected to boost the growth of the molecular diagnostics market in Asia Pacific.

Request a sample to get extensive insights into the Molecular Diagnostics Market

Unprecedented Demand for RT-PCR Test During COVID-19 Pandemic Propelling Market Growth

In order to keep the economies running amid the ongoing COVID-19 outbreak, companies in the global molecular diagnostics market are increasing R&D in PCR (Polymerase Chain Reaction) & real-time PCR, hybridization, microarray, transcription-mediated amplification, next-generation sequencing, etc.

The PCR & real-time PCR segment accounted for a leading revenue share of the global market in 2020. The segment is likely to witness strong growth during the forecast period, as the PCR technique is a cost-effective way of copying or amplification of small segments of DNA or RNA. The unprecedented demand for RT-PCR test during the ongoing pandemic is propelling the market growth.

To understand how our report can bring difference to your business strategy, Ask for a brochure

Lack of Awareness about Molecular Diagnostic Tests Affecting Market Expansion

Less awareness and ambiguity about diagnostic techniques for detecting various infectious & chronic diseases is a major factor limiting the penetration of tests, such as HIV test, healthcare acquired infection test, and rapid molecular tests in the mycobacterium tuberculosis into the molecular diagnostics market. Therefore, small and medium community medical practitioners in emerging economies such as China and India need to be educated about the availability of these tests, and how these can be used for the prevention and diagnosis of chronic diseases. Stakeholders in the molecular diagnostics market should increase marketing and awareness about molecular diagnostic tests to increase its acceptance among people in developing economies.

Stuck in a neck-to-neck competition with other brands? Request a custom report on Molecular Diagnostics Market

Increase in Adoption of Molecular Diagnostic Devices in Europe Driving Global Market

Companies in the Europe molecular diagnostics market are focusing on hospitals, diagnostic laboratories, academic & research institutes, and pharmaceutical & biotechnology companies to expand their business activities. Pharmaceutical and biotechnology companies are anticipated to be the fastest growing segment, owing to their increasing investments on research that contributes to the growth in adoption of molecular diagnostic devices. This segment is closely trailed by academic and research institutes. The growth in this segment can be attributed to the increasing public and private funding for research. European funding organizations are supporting innovative companies in the development of new products and are conducting annual PCR conferences to identify potential innovators of PCR technology.

Automation Technologies Growing Prominent in Molecular Diagnostics

The demand for molecular diagnostic systems has been increasing, owing to the increasing automation in the research process. These systems aid in automating the process of DNA extraction, amplification, and recording the analysis of data. In addition, these systems offer a range of advantages such as increased efficiency, correctness of the data, and decrease in the time required for results, which contribute to garner market growth. 

Companies are increasing efforts toward high-throughput molecular testing of infectious diseases. They are entering into agreements to provide molecular diagnostic tests, which are designed for the detection of various pathogens with a single patient sample.

Molecular Diagnostics Market – Scope of Report

  • According to Transparency Market Research’s latest report on the global molecular diagnostics market for the historical period 2017–2019 and forecast period 2021–2028, increase in geriatric population, rise in demand for personalized health care, and surge in awareness about molecular diagnostics are the key factors projected to drive the global molecular diagnostics market during the forecast period

Rise in Prevalence Infectious Diseases and Cancer: Key Driver

  • According to the World Health Organization (WHO), cancer accounts for 8.3 million deaths globally each year, with 70% new cancer cases expected to be reported in the next 20 years. Each cancer type requires unique treatment. Hence, rise in prevalence of cancer and the need of personalized medicine are expected to drive demand for molecular diagnostics during the forecast period. This is likely to provide significant opportunities to players in the market, as it is still in a nascent stage.

Increase in Government Investment in Diagnostic Health Care to Boost Market Growth

  • Governments of several countries are investing in diagnostic health care. According to the World Bank, global public expenditure was 6% of the GDP.
    • In the past few years, the health care spending in the U.S. increased by 5.8% to reach US$ 3.2 Trn. The overall share of the U.S. economy devoted to health care spending was 17.8% in 2015, up from 17.4% in 2014.
    • In 2014, total health care expenditure of the general government in Europe was 7.2% of GDP

Lack of Awareness to Hamper Market

  • Less awareness and ambiguity about diagnostic techniques for detecting various infectious and chronic diseases is a major factor limiting the penetration of tests, such as HIV test, health care acquired infection test, and rapid molecular tests for mycobacterium tuberculosis, into the molecular diagnostics market. Therefore, small and medium community medical practitioners in emerging economies such as China and India need to be educated about the availability of these tests and how these can be used for the prevention and diagnosis of chronic diseases.
  • Late diagnosis of any disease results in increase in the cost of treatment

Molecular Diagnostics Market: Competition Landscape

  • This report profiles major players in the global molecular diagnostics market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments
  • The global molecular diagnostics market is highly fragmented, with the presence of a number of international as well as regional players
  • Leading players operating in the global molecular diagnostics market are
    • Abbot Laboratories
    • Becton
    • Dickinson and Company
    • Bio-Rad Laboratories, Inc.
    • bioMérieux SA
    • Danaher Corporation
    • F. Hoffmann-La Roche Ltd.
    • QIAGEN N.V.
    • Siemens AG
    • Thermo Fisher Scientific, Inc., among others

Molecular Diagnostics Market: Key Developments

  • Key players in the global molecular diagnostics market are engaged in regulatory approvals, technologically advanced products, launch of new products, and acquisition & collaborative agreements with other companies. These strategies are likely to fuel the growth of the global molecular diagnostics market in the next few years.
  • A few expansion strategies adopted by players operating in the global molecular diagnostics market are:
    • In December 2021, Becton, Dickinson and Company (BD) announced expansion of its BD COR system to include MX instruments for high-throughput molecular testing of infectious diseases
    • In March 2021, Roche announced an agreement to acquire GenMark Diagnostics. This acquisition has been carried out so that GenMark can provide molecular diagnostic tests, which are designed for the detection of various pathogens with a single patient sample.
  • The report on the global molecular diagnostics market discusses individual strategies, followed by company profiles of manufacturers of stem cell products. The competition landscape section has been included in the report to provide readers with a dashboard view and a company market share analysis of key players operating in the global molecular diagnostics market.

Molecular Diagnostics Market Snapshot

Attribute

Detail

Market Size Value in 2020

US$ 14.99 Bn

Market Forecast Value in 2028

US$ 37.19 Bn

Growth Rate (CAGR)

11.1%

Forecast Period

2021–2028

Quantitative Units

US$ Bn for Value

Market Analysis

It includes cross segment analysis at global as well as regional level. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, and parent industry overview.

Competition Landscape

  • Market share analysis by company (2020)
  • Company profiles section includes overview, product portfolio, sales footprint, key subsidiaries or distributors, strategy & recent developments, and key financials

Format

Electronic (PDF) + Excel

Market Segmentation

  • By Technology
    • PCR & Real time PCR
    • Hybridization
    • Microarray
    • Transcription-mediated Amplification
    • Next Generation Sequencing
    • Others
  • Application
    • Infectious Diseases
    • Oncology
    • Blood Screening
    • Microbiology
    • Genetic Testing
    • Women's Health
  • End-user
    • Hospitals
    • Diagnostic Laboratories
    • Blood Banks
    • Academics & Research
    • Others

Regions Covered

  • North America
  • Latin America
  • Europe
  • Latin America
  • Middle East & Africa

Countries Covered

  • U.S.
  • Canada
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • China
  • India
  • Japan
  • Australia & New Zealand
  • Brazil
  • Mexico
  • GCC Countries
  • South Africa

Companies Profiled

  • STEMCELL Technologies, Inc.
  • Astellas Pharma, Inc.
  • Cellular Engineering Technologies, Inc.
  • BioTime, Inc.
  • Takara Bio, Inc.
  • U.S. Stem Cell, Inc.
  • BrainStorm Cell Therapeutics, Inc.
  • Cytori Therapeutics, Inc.
  • Osiris Therapeutics, Inc.
  • Caladrius Biosciences, Inc.
  • Others

Customization Scope

Available upon request

Pricing

Available upon request

Molecular Diagnostics Market – Segmentation

Technology
  • PCR & Real-time PCR
  • Hybridization
  • Microarray
  • Transcription-mediated Amplification
  • Next-Generation Sequencing
  • Others
Application
  • Infectious Diseases
  • Virology
  • Bacteriology
  • Oncology
  • Blood Screening
  • Microbiology
  • Genetic Testing
  • Women's Health
End-user
  • Hospitals
  • Diagnostic Laboratories
  • Blood Banks
  • Academics & Research
  • Others
Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Frequently Asked Questions

The global molecular diagnostics market was worth US$ 14.99 Mn and is projected to reach a value of US$ 37.19 Bn by the end of 2028

Molecular diagnostics market is anticipated to grow at a CAGR of 11.1% during the forecast period

North America accounted for a major share of the global molecular diagnostics market

Molecular diagnostics market is driven by increase in geriatric population, rise in demand for personalized health care, and surge in awareness about molecular diagnostics are the key factors projected to drive the global market during the forecast period

Key players in the global molecular diagnostics market include Abbot Laboratories, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., bioMérieux SA, Danaher Corporation, F. Hoffmann-La Roche Ltd., QIAGEN N.V., Siemens AG, and Thermo Fisher Scientific, Inc.

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Molecular Diagnostics Market

4. Market Overview

    4.1. Introduction

        4.1.1. End-user Definition

    4.2. Overview

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunities

    4.4. Global Molecular Diagnostics Market Analysis and Forecast, 2017–2028

        4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

    5.1. Future Market Outlook

    5.2. Key Industry Events

    5.3. Porter’s Five Force Analysis

    5.4. COVID-19 Pandemics Impact on Industry (value chain and short / mid / long term impact)

6. Global Molecular Diagnostics Market Analysis and Forecast, by End-user

    6.1. Introduction & Definition

    6.2. Key Findings / Developments

    6.3. Market Value Forecast, by End-user, 2017–2028

        6.3.1. PCR & Real-time PCR

        6.3.2. Hybridization

        6.3.3. Microarray

        6.3.4. Transcription-mediated Amplification

        6.3.5. Next-Generation Sequencing

        6.3.6. Others

    6.4. Market Attractiveness Analysis, by End-user

7. Global Molecular Diagnostics Market Analysis and Forecast, by Application

    7.1. Introduction & Definition

    7.2. Key Findings / Developments

    7.3. Market Value Forecast, by Application, 2017–2028

        7.3.1. Infectious Diseases

            7.3.1.1. Virology

            7.3.1.2. Bacteriology

        7.3.2. Oncology

        7.3.3. Blood Screening

        7.3.4. Microbiology

        7.3.5. Genetic Testing

        7.3.6. Women’s Health

    7.4. Market Attractiveness Analysis, by Application

8. Global Molecular Diagnostics Market Analysis and Forecast, by End-user

    8.1. Introduction & Definition

    8.2. Key Findings / Developments

    8.3. Market Value Forecast, by End-user, 2017–2028

        8.3.1. Hospitals

        8.3.2. Diagnostics Laboratories

        8.3.3. Blood Banks

        8.3.4. Academics & Research

        8.3.5. Others

    8.4. Market Attractiveness Analysis, by End-user

9. Global Molecular Diagnostics Market Analysis and Forecast, by Region

    9.1. Key Findings

    9.2. Market Value Forecast, by Region

        9.2.1. North America

        9.2.2. Europe

        9.2.3. Asia Pacific

        9.2.4. Latin America

        9.2.5. Middle East & Africa

    9.3. Market Attractiveness Analysis, by Region

10. North America Molecular Diagnostics Market Analysis and Forecast

    10.1. Introduction

        10.1.1. Key Findings

    10.2. Market Value Forecast, by End-user, 2017–2028

        10.2.1. PCR & Real-time PCR

        10.2.2. Hybridization

        10.2.3. Microarray

        10.2.4. Transcription-mediated Amplification

        10.2.5. Next-Generation Sequencing

        10.2.6. Others

    10.3. Market Value Forecast, by Application, 2017–2028

        10.3.1. Infectious Diseases

            10.3.1.1. Virology

            10.3.1.2. Bacteriology

        10.3.2. Oncology

        10.3.3. Blood Screening

        10.3.4. Microbiology

        10.3.5. Genetic Testing

        10.3.6. Women’s Health

    10.4. Market Value Forecast, by End-user, 2017–2028

        10.4.1. Hospitals

        10.4.2. Diagnostics Laboratories

        10.4.3. Blood Banks

        10.4.4. Academics & Research

        10.4.5. Others

    10.5. Market Value Forecast, by Country, 2017–2028

        10.5.1. U.S.

        10.5.2. Canada

    10.6. Market Attractiveness Analysis

        10.6.1. By End-user

        10.6.2. By Application

        10.6.3. By End-user

        10.6.4. By Country

11. Europe Molecular Diagnostics Market Analysis and Forecast

    11.1. Introduction

        11.1.1. Key Findings

    11.2. Market Value Forecast, by End-user, 2017–2028

        11.2.1. PCR & Real-time PCR

        11.2.2. Hybridization

        11.2.3. Microarray

        11.2.4. Transcription-mediated Amplification

        11.2.5. Next-Generation Sequencing

        11.2.6. Others

    11.3. Market Value Forecast, by Application, 2017–2028

        11.3.1. Infectious Diseases

            11.3.1.1. Virology

            11.3.1.2. Bacteriology

        11.3.2. Oncology

        11.3.3. Blood Screening

        11.3.4. Microbiology

        11.3.5. Genetic Testing

        11.3.6. Women’s Health

    11.4. Market Value Forecast, by End-user, 2017–2028

        11.4.1. Hospitals

        11.4.2. Diagnostics Laboratories

        11.4.3. Blood Banks

        11.4.4. Academics & Research

        11.4.5. Others

    11.5. Market Value Forecast, by Country/Sub-region, 2017–2028

        11.5.1. Germany

        11.5.2. U.K.

        11.5.3. France

        11.5.4. Italy

        11.5.5. Spain

        11.5.6. Rest of Europe

    11.6. Market Attractiveness Analysis

        11.6.1. By End-user

        11.6.2. By Application

        11.6.3. By End-user

        11.6.4. By Country/Sub-region

12. Asia Pacific Molecular Diagnostics Market Analysis and Forecast

    12.1. Introduction

        12.1.1. Key Findings

    12.2. Market Value Forecast, by End-user, 2017–2028

        12.2.1. PCR & Real-time PCR

        12.2.2. Hybridization

        12.2.3. Microarray

        12.2.4. Transcription-mediated Amplification

        12.2.5. Next-Generation Sequencing

        12.2.6. Others

    12.3. Market Value Forecast, by Application, 2017–2028

        12.3.1. Infectious Diseases

            12.3.1.1. Virology

            12.3.1.2. Bacteriology

        12.3.2. Oncology

        12.3.3. Blood Screening

        12.3.4. Microbiology

        12.3.5. Genetic Testing

        12.3.6. Women’s Health

    12.4. Market Value Forecast, by End-user, 2017–2028

        12.4.1. Hospitals

        12.4.2. Diagnostics Laboratories

        12.4.3. Blood Banks

        12.4.4. Academics & Research

        12.4.5. Others

    12.5. Market Value Forecast, by Country/Sub-region, 2017–2028

        12.5.1. China

        12.5.2. Japan

        12.5.3. India

        12.5.4. Australia & New Zealand

        12.5.5. Rest of Asia Pacific

    12.6. Market Attractiveness Analysis

        12.6.1. By End-user

        12.6.2. By Application

        12.6.3. By End-user

        12.6.4. By Country/Sub-region

13. Latin America Molecular Diagnostics Market Analysis and Forecast

    13.1. Introduction

        13.1.1. Key Findings

    13.2. Market Value Forecast, by End-user, 2017–2028

        13.2.1. PCR & Real-time PCR

        13.2.2. Hybridization

        13.2.3. Microarray

        13.2.4. Transcription-mediated Amplification

        13.2.5. Next-Generation Sequencing

        13.2.6. Others

    13.3. Market Value Forecast, by Application, 2017–2028

        13.3.1. Infectious Diseases

            13.3.1.1. Virology

            13.3.1.2. Bacteriology

        13.3.2. Oncology

        13.3.3. Blood Screening

        13.3.4. Microbiology

        13.3.5. Genetic Testing

        13.3.6. Women’s Health

    13.4. Market Value Forecast, by End-user, 2017–2028

        13.4.1. Hospitals

        13.4.2. Diagnostics Laboratories

        13.4.3. Blood Banks

        13.4.4. Academics & Research

        13.4.5. Others

    13.5. Market Value Forecast, by Country/Sub-region, 2017–2028

        13.5.1. Brazil

        13.5.2. Mexico

        13.5.3. Rest of Latin America

    13.6. Market Attractiveness Analysis

        13.6.1. By End-user

        13.6.2. By Application

        13.6.3. By End-user

        13.6.4. By Country/Sub-region

14. Middle East & Africa Molecular Diagnostics Market Analysis and Forecast

    14.1. Introduction

        14.1.1. Key Findings

    14.2. Market Value Forecast, by End-user, 2017–2028

        14.2.1. PCR & Real-time PCR

        14.2.2. Hybridization

        14.2.3. Microarray

        14.2.4. Transcription-mediated Amplification

        14.2.5. Next-Generation Sequencing

        14.2.6. Others

    14.3. Market Value Forecast, by Application, 2017–2028

        14.3.1. Infectious Diseases

            14.3.1.1. Virology

            14.3.1.2. Bacteriology

        14.3.2. Oncology

        14.3.3. Blood Screening

        14.3.4. Microbiology

        14.3.5. Genetic Testing

        14.3.6. Women’s Health

    14.4. Market Value Forecast, by End-user, 2017–2028

        14.4.1. Hospitals

        14.4.2. Diagnostics Laboratories

        14.4.3. Blood Banks

        14.4.4. Academics & Research

        14.4.5. Others

    14.5. Market Value Forecast, by Country/Sub-region, 2017–2028

        14.5.1. GCC Countries

        14.5.2. South Africa

        14.5.3. Rest of Middle East & Africa

    14.6. Market Attractiveness Analysis

        14.6.1. By End-user

        14.6.2. By Application

        14.6.3. By End-user

        14.6.4. By Country/Sub-region

15. Competition Landscape

    15.1. Market Player - Competition Matrix (by tier and size of companies)

    15.2. Market Share Analysis, by Company, 2020

    15.3. Company Profiles

        15.3.1. Abbott Laboratories

            15.3.1.1. Company Overview

            15.3.1.2. Business Overview

            15.3.1.3. Financial Overview

            15.3.1.4. SWOT Analysis

            15.3.1.5. Strategic Overview

        15.3.2. Becton, Dickinson and Company

            15.3.2.1. Company Overview

            15.3.2.2. Business Overview

            15.3.2.3. Financial Overview

            15.3.2.4. SWOT Analysis

            15.3.2.5. Strategic Overview

        15.3.3. Bio-Rad Laboratories, Inc.

            15.3.3.1. Company Overview

            15.3.3.2. Business Overview

            15.3.3.3. Financial Overview

            15.3.3.4. SWOT Analysis

            15.3.3.5. Strategic Overview

        15.3.4. BioMérieux SA

            15.3.4.1. Company Overview

            15.3.4.2. Business Overview

            15.3.4.3. Financial Overview

            15.3.4.4. SWOT Analysis

            15.3.4.5. Strategic Overview

        15.3.5. Danaher Corporation

            15.3.5.1. Company Overview

            15.3.5.2. Business Overview

            15.3.5.3. Financial Overview

            15.3.5.4. SWOT Analysis

            15.3.5.5. Strategic Overview

        15.3.6. F. Hoffmann-La Roche Ltd.

            15.3.6.1. Company Overview

            15.3.6.2. Business Overview

            15.3.6.3. Financial Overview

            15.3.6.4. SWOT Analysis

            15.3.6.5. Strategic Overview

        15.3.7. QIAGEN N.V.

            15.3.7.1. Company Overview

            15.3.7.2. Business Overview

            15.3.7.3. Financial Overview

            15.3.7.4. SWOT Analysis

            15.3.7.5. Strategic Overview

        15.3.8. Siemens AG

            15.3.8.1. Company Overview

            15.3.8.2. Business Overview

            15.3.8.3. Financial Overview

            15.3.8.4. SWOT Analysis

            15.3.8.5. Strategic Overview

        15.3.9. Thermo Fisher Scientific Inc.

            15.3.9.1. Company Overview

            15.3.9.2. Business Overview

            15.3.9.3. Financial Overview

            15.3.9.4. SWOT Analysis

            15.3.9.5. Strategic Overview

List of Table

Table 01: Global Molecular Diagnostics Market Size (US$ Mn) Forecast, by Technology, 2017–2028

Table 02: Global Molecular Diagnostics Market Size (US$ Mn) Forecast, by Application, 2017–2028

Table 03: Global Molecular Diagnostics Market Size (US$ Mn) Forecast, by Infectious Diseases, 2017–2028

Table 04: Global Molecular Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2017–2028

Table 05: Global Molecular Diagnostics Market Size (US$ Mn) Forecast, by Region, 2017–2028

Table 06: North America Molecular Diagnostics Market Size (US$ Mn) Forecast, by Technology Type, 2017–2028

Table 07: North America Molecular Diagnostics Market Size (US$ Mn) Forecast, by Application, 2017–2028

Table 08: North America Molecular Diagnostics Market Size (US$ Mn) Forecast, by Infectious Diseases, 2017–2028

Table 09: North America Molecular Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2017–2028

Table 10: North America Molecular Diagnostics Market Size (US$ Mn) Forecast, by Country, 2017–2028

Table 11: Europe Molecular Diagnostics Market Size (US$ Mn) Forecast, by Technology, 2017–2028

Table 12: Europe Molecular Diagnostics Market Size (US$ Mn) Forecast, by Application, 2017–2028

Table 13: Europe Molecular Diagnostics Market Size (US$ Mn) Forecast, by Infectious Diseases, 2017–2028

Table 14: Europe Molecular Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2017–2028

Table 15: Europe Molecular Diagnostics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2028

Table 16: Asia Pacific Molecular Diagnostics Market Size (US$ Mn) Forecast, by Technology Type, 2017–2028

Table 17: Asia Pacific Molecular Diagnostics Market Size (US$ Mn) Forecast, by Application, 2017–2028

Table 18: Asia Pacific Molecular Diagnostics Market Size (US$ Mn) Forecast, by Infectious Diseases, 2017–2028

Table 19: Asia Pacific Molecular Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2017–2028

Table 20: Asia Pacific Molecular Diagnostics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2028

Table 21: Latin America Molecular Diagnostics Market Size (US$ Mn) Forecast, by Technology Type, 2017–2028

Table 22: Latin America Molecular Diagnostics Market Size (US$ Mn) Forecast, by Application, 2017–2028

Table 23: Latin America Molecular Diagnostics Market Size (US$ Mn) Forecast, by Infectious Diseases, 2017–2028

Table 24: Latin America Molecular Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2017–2028

Table 25: Latin America Molecular Diagnostics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2028

Table 26: Middle East & Africa Molecular Diagnostics Market Size (US$ Mn) Forecast, by Technology, 2017–2028

Table 27: Middle East & Africa Molecular Diagnostics Market Size (US$ Mn) Forecast, by Application, 2017–2028

Table 28: Middle East & Africa Molecular Diagnostics Market Size (US$ Mn) Forecast, by Infectious Diseases, 2017–2028

Table 29: Middle East & Africa Molecular Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2017–2028

Table 30: Middle East & Africa Molecular Diagnostics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2028

List of Figure

Figure 1: Global Molecular Diagnostic Market Size (US$ Mn) Forecast, 2017–2028

Figure 2: Global Molecular Diagnostics Market Value Share, by Technology, 2020

Figure 3: Global Molecular Diagnostics Market Value Share, by Application, 2020

Figure 4: Global Molecular Diagnostics Market Value Share, by Region, 2020

Figure 5: Global Molecular Diagnostics Market Value Share, by End-user, 2020

Figure 6: Global Molecular Diagnostic Market Value Share Analysis, by Technology, 2017 and 2028

Figure 7: Global Molecular Diagnostic Market Attractiveness Analysis, by Technology, 2021–2028

Figure 8: Global PCR & Real-time PCR Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2017–2028

Figure 9: Global Hybridization Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2017–2028

Figure 10: Global Microarray Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2017–2028

Figure 11: Global Transcription-mediated Amplification Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2017–2028

Figure 12: Global Next-Generation Sequencing Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2017–2028

Figure 13: Global Others (Mass Spectrometry etc.) Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2017–2028

Figure 14: Global Molecular Diagnostics Market Value Share Analysis, by Application, 2017 and 2028

Figure 15: Global Molecular Diagnostics Market Attractiveness Analysis, by Application, 2021–2022

Figure 16: Global Infectious Diseases Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2017–2028

Figure 17: Global Oncology Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2017–2028

Figure 18: Global Blood Screening Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2017–2028

Figure 19: Global Microbiology Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2017–2028

Figure 20: Global Genetic Testing Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2017–2028

Figure 21: Global Women’s Health Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2017–2028

Figure 22: Global Molecular Diagnostic Market Value Share Analysis, by End-user, 2017 and 2028

Figure 23: Global Molecular Diagnostic Market Attractiveness Analysis, by End-user, 2021–2022

Figure 24: Global Hospital Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2017–2028

Figure 25: Global Diagnostic Laboratories Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2017–2028

Figure 26: Global Blood Banks Centers Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2017–2028

Figure 27: Global Academics & Research Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2017–2028

Figure 28: Global Others Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2017–2028

Figure 29: Global Molecular Diagnostics Market Value Share Analysis, by Region, 2017 and 2028

Figure 30: Global Molecular Diagnostics Market Attractiveness Analysis, by Region, 2021–2022

Figure 31: North America Molecular Diagnostics Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2028

Figure 32: North America Molecular Diagnostics Market Attractiveness Analysis, by Country, 2021–2022

Figure 33: North America Market Value Share Analysis, by Technology Type, 2017 and 2028

Figure 34: North America Market Value Share Analysis, by Application, 2017 and 2028

Figure 35: North America Market Value Share Analysis, by End-user, 2017 and 2028

Figure 36: North America Market Value Share Analysis, by Country, 2017 and 2028

Figure 37: North America Market Attractiveness Analysis, by Technology, 2021–2022

Figure 38: North America Market Attractiveness Analysis, by Application, 2021–2022

Figure 39: North America Market Attractiveness Analysis, by End-user, 2021–2022

Figure 40: Europe Molecular Diagnostics Market Size (US$ Mn) Forecast, 2017–2028

Figure 41: Europe Molecular Diagnostics Market Attractiveness Analysis, by Country, 2021–2022

Figure 42: Europe Molecular Diagnostics Market Value Share Analysis, by Technology, 2017 and 2028

Figure 43: Europe Molecular Diagnostics Market Value Share Analysis, by Application, 2017 and 2028

Figure 44: Europe Molecular Diagnostics Market Value Share Analysis, by End-user, 2017 and 2028

Figure 45: Europe Molecular Diagnostics Market Value Share Analysis, by Country, 2017 and 2028

Figure 46: Europe Molecular Diagnostics Market Attractiveness Analysis, by Technology, 2021–2022

Figure 47: Europe Molecular Diagnostics Market Attractiveness Analysis, by Application, 2021–2022

Figure 48: Europe Molecular Diagnostics Market Attractiveness Analysis, by End-user, 2021–2022

Figure 49: Asia Pacific Molecular Diagnostics Market Size (US$ Mn) Forecast, 2017–2028

Figure 50: Asia Pacific Molecular Diagnostics Market Attractiveness Analysis, by Country, 2021–2022

Figure 51: Asia Pacific Market Value Share Analysis, by Technology Type, 2017 and 2028

Figure 52: Asia Pacific Market Value Share Analysis, by Application, 2017 and 2028

Figure 53: Asia Pacific Market Value Share Analysis, by End-user, 2017 and 2028

Figure 54: Asia Pacific Market Value Share Analysis, by Country, 2017 and 2028

Figure 55: Asia Pacific Market Attractiveness Analysis, by Technology, 2021–2022

Figure 56: Asia Pacific Market Attractiveness Analysis, by Application, 2021–2022

Figure 57: Asia Pacific Market Attractiveness Analysis, by End-user, 2021–2022

Figure 58: Latin America Molecular Diagnostics Market Size (US$ Mn) Forecast, 2017–2028

Figure 59: Latin America Molecular Diagnostics Market Attractiveness Analysis, by Country, 2021–2022

Figure 60: Latin America Market Value Share Analysis, by Technology Type, 2017 and 2028

Figure 61: Latin America Market Value Share Analysis, by Application, 2017 and 2028

Figure 62: Latin America Market Value Share Analysis, by End-user, 2017 and 2028

Figure 63: Latin America Market Value Share Analysis, by Country, 2017 and 2028

Figure 64: Latin America Market Attractiveness Analysis, by Technology, 2021–2022

Figure 65: Latin America Market Attractiveness Analysis, by Application, 2021–2022

Figure 66: Latin America Market Attractiveness Analysis, by End-user, 2021–2022

Figure 67: Middle East & Africa Molecular Diagnostics Market Size (US$ Mn) Forecast, 2017–2028

Figure 68: Middle East & Africa Molecular Diagnostics Market Attractiveness Analysis, by Country, 2021–2022

Figure 69: Middle East & Africa Market Value Share Analysis, by Technology Type, 2017 and 2028

Figure 70: Middle East & Africa Market Value Share Analysis, by Application, 2017 and 2028

Figure 71: Middle East & Africa Market Value Share Analysis, by End-user, 2017 and 2028

Figure 72: Middle East & Africa Market Value Share Analysis, by Country, 2017 and 2028

Figure 73: Middle East & Africa Market Attractiveness Analysis, by Technology, 2021–2022

Figure 74: Middle East & Africa Market Attractiveness Analysis, by Application, 2021–2022

Figure 75: Middle East & Africa Market Attractiveness Analysis, by End-user, 2021–2022

Figure 76: Global Molecular Diagnostics Market Share Analysis, by Company

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

Request Customization

Molecular Diagnostics Market